Goldenwell Biotech, Inc. is a development stage company, which engages in the research & development and industrialization of healthcare products, bio-pharmaceuticals and bio-engineering drugs, and food and cosmetics products. The firm plans to develop, manufacture and market five products: Bovine Cardiac Vascular Active Peptide, Double Proline AG-3D Active Collagen Peptide, Cartilage Peptide-Type II Collagen Peptide, DNA Repair, and Sugar Master. The company was founded on August 20, 2019 and is headquartered in Solon, OH.
Sector:
Health Technology
Industry:
Pharmaceuticals Other
Employees:
3
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Goldenwell Biotech Inc market cap is $56.92M.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Goldenwell Biotech Inc 52 week high is $3.00 as of November 22, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Goldenwell Biotech Inc 52 week low is $0.51 as of November 22, 2026.
Goldenwell Biotech Inc stock price today is $0.60.
Goldenwell Biotech Inc stock price yesterday was $0.55.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Goldenwell Biotech Inc's P/E ratio is -206.9.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Goldenwell Biotech Inc P/B ratio is -138.2488.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Goldenwell Biotech Inc 50-day moving average is $0.6553.